1-N-BOC-3-BROMOPIPERIDINE CAS: 849928-26-3

CAS NO: 849928-26-3
1-N-BOC-3-BROMOPIPERIDINE
Chemical Name: 1-N-BOC-3-BROMOPIPERIDINE
Molecular Formula: C10H18BrNO2
Formula Weight: 264.16
CAS No.: 849928-26-3
Description Review
Description

1-N-BOC-3-Bromopiperidine, also known as 1-tert-butoxycarbonyl-3-bromopiperidine, is a chemical compound that belongs to the class of piperidine derivatives. This compound has received significant attention in recent years due to its potential applications in various fields such as pharmaceuticals, agrochemicals, and materials science. In this article, we will discuss the properties, health benefits, potential effects, product mechanism, safety, side effects, dosing information, and conclusion of 1-N-BOC-3-Bromopiperidine.

Chemical name:

1-N-BOC-3-Bromopiperidine

Molecular formula:

C11H19BrN2O2

Formula weight:

293.18 g/mol

CAS No:

849928-26-3

Top ten keywords from Google and synonyms:

  1. Piperidine derivative
  2. Bromopiperidine
  3. 3-bromo-1-tert-butoxycarbonylpiperidine
  4. BOC-protected bromopiperidine
  5. Chemical intermediate
  6. Organic synthesis
  7. Pharmaceutical intermediate
  8. Agrochemical intermediate
  9. Materials science
  10. N-BOC-3-bromopiperidine

Health benefits of this product:

There are no direct health benefits associated with 1-N-BOC-3-Bromopiperidine. However, it is an important intermediate in the synthesis of various pharmaceuticals and agrochemicals, which can have positive health impacts.

Potential effects:

1-N-BOC-3-Bromopiperidine is a versatile compound that can be used as a building block for the synthesis of various biologically active molecules. It can act as an intermediate in the synthesis of anticancer agents, antitumor agents, and antiviral agents. It can also be used as an intermediate in the synthesis of insecticides and fungicides.

Product mechanism:

1-N-BOC-3-Bromopiperidine acts as a precursor or building block for the synthesis of various biologically active molecules. It is primarily used in organic synthesis to introduce the piperidine and bromine moieties into molecules. The BOC group provides protection to the amine during the synthesis process and can be removed later to reveal the free amine group.

Safety:

1-N-BOC-3-Bromopiperidine should be handled with care as it is a toxic and hazardous compound. It should only be used by trained professionals in a well-equipped laboratory setting. The compound should be stored in a cool, dry place away from sunlight and heat sources. Safety equipment such as gloves, goggles, and lab coats should be worn when handling this compound.

Side effects:

As 1-N-BOC-3-Bromopiperidine is not intended for human consumption or use, there are no known side effects associated with its use. However, exposure to this compound may cause skin irritation, eye irritation, or respiratory problems. In case of accidental ingestion or exposure, seek immediate medical attention.

Dosing information:

There is no established dosing information for 1-N-BOC-3-Bromopiperidine as it is primarily used as an intermediate in the synthesis of other compounds. The amount used in each synthesis reaction may vary depending on the specific application.

Conclusion:

In conclusion, 1-N-BOC-3-Bromopiperidine is a versatile intermediate that has potential applications in the pharmaceutical, agrochemical, and materials science industries. Its primary function is as a building block for the synthesis of various biologically active molecules. As with any chemical compound, it should be handled with care and only used by trained professionals in a well-equipped laboratory setting. Overall, 1-N-BOC-3-Bromopiperidine is an important compound that plays a crucial role in the development of many useful products

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code